Overview

Sildenafil in COVID-19

Status:
Completed
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
This randomised trial aims to assess the role of sildenafil in improving oxygenation amongst hospitalised patients with COVID19.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Universidad Nacional Andres Bello
Collaborator:
Hospital Naval Almirante Nef, Viña del Mar, Chile
Treatments:
Sildenafil Citrate